465 related articles for article (PubMed ID: 29313389)
41. Multitarget Stool RNA Test for Colorectal Cancer Screening.
Barnell EK; Wurtzler EM; La Rocca J; Fitzgerald T; Petrone J; Hao Y; Kang Y; Holmes FL; Lieberman DA
JAMA; 2023 Nov; 330(18):1760-1768. PubMed ID: 37870871
[TBL] [Abstract][Full Text] [Related]
42. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
[TBL] [Abstract][Full Text] [Related]
43. Assessment of Stool DNA Markers to Detect Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: A Multi-site Case-control Study.
Itzkowitz S; Farraye FA; Limburg PJ; Gagrat Z; Olson MC; Zella J; Kisiel JB
J Crohns Colitis; 2023 Oct; 17(9):1436-1444. PubMed ID: 37166153
[TBL] [Abstract][Full Text] [Related]
44. Long-term Follow-up of Patients Having False-Positive Multitarget Stool DNA Tests after Negative Screening Colonoscopy: The LONG-HAUL Cohort Study.
Cotter TG; Burger KN; Devens ME; Simonson JA; Lowrie KL; Heigh RI; Mahoney DW; Johnson DH; Ahlquist DA; Kisiel JB
Cancer Epidemiol Biomarkers Prev; 2017 Apr; 26(4):614-621. PubMed ID: 27999144
[No Abstract] [Full Text] [Related]
45. Detection of High-Risk Sessile Serrated Lesions: Multitarget Stool DNA Versus CT Colonography.
Deiss-Yehiely N; Graffy PM; Weigman B; Hassan C; Matkowskyj KA; Pickhardt PJ; Weiss JM
AJR Am J Roentgenol; 2022 Apr; 218(4):670-676. PubMed ID: 34755523
[No Abstract] [Full Text] [Related]
46. Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis.
Kisiel JB; Konijeti GG; Piscitello AJ; Chandra T; Goss TF; Ahlquist DA; Farraye FA; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1778-1787.e8. PubMed ID: 27464589
[TBL] [Abstract][Full Text] [Related]
47. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
Fisher DA; Karlitz JJ; Jeyakumar S; Smith N; Limburg P; Lieberman D; Fendrick AM
J Med Econ; 2021; 24(1):654-664. PubMed ID: 33902366
[TBL] [Abstract][Full Text] [Related]
48. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
49. Multi-target stool DNA test: a new high bar for noninvasive screening.
Ahlquist DA
Dig Dis Sci; 2015 Mar; 60(3):623-33. PubMed ID: 25492503
[TBL] [Abstract][Full Text] [Related]
50. Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model.
Piscitello A; Saoud L; Fendrick AM; Borah BJ; Hassmiller Lich K; Matney M; Ozbay AB; Parton M; Limburg PJ
PLoS One; 2020; 15(12):e0244431. PubMed ID: 33373409
[TBL] [Abstract][Full Text] [Related]
51. Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.
Rigter LS; Spaander MC; Moons LM; Bisseling TM; Aleman BM; de Boer JP; Lugtenburg PJ; Janus CP; Petersen EJ; Roesink JM; Raemaekers JM; van der Maazen RW; Cats A; Bleiker EM; Snaebjornsson P; Carvalho B; Lansdorp-Vogelaar I; Jóźwiak K; Te Riele H; Meijer GA; van Leeuwen FE; van Leerdam ME
BMC Cancer; 2017 Feb; 17(1):112. PubMed ID: 28173773
[TBL] [Abstract][Full Text] [Related]
52. Fecal immunochemical test accuracy in familial risk colorectal cancer screening.
Castro I; Cubiella J; Rivera C; González-Mao C; Vega P; Soto S; Hernandez V; Iglesias F; Teresa Alves M; Bujanda L; Fernández-Seara J
Int J Cancer; 2014 Jan; 134(2):367-75. PubMed ID: 23818169
[TBL] [Abstract][Full Text] [Related]
53. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
54. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population.
Imperiale TF; Ransohoff DF; Itzkowitz SH; Turnbull BA; Ross ME;
N Engl J Med; 2004 Dec; 351(26):2704-14. PubMed ID: 15616205
[TBL] [Abstract][Full Text] [Related]
55. Stool DNA screening for colorectal neoplasia: biological and technical basis for high detection rates.
Berger BM; Ahlquist DA
Pathology; 2012 Feb; 44(2):80-8. PubMed ID: 22198259
[TBL] [Abstract][Full Text] [Related]
56. Evaluating Outreach Methods for Multi-Target Stool DNA Test for Colorectal Cancer Screening Among an Employer Population.
Shepherd ME; Lecorps A; Harris-Shapiro J; Miller-Wilson LA
J Prim Care Community Health; 2021; 12():21501327211037892. PubMed ID: 34382887
[TBL] [Abstract][Full Text] [Related]
57. Barriers to Follow-Up Colonoscopy After Positive FIT or Multitarget Stool DNA Testing.
Cooper GS; Grimes A; Werner J; Cao S; Fu P; Stange KC
J Am Board Fam Med; 2021; 34(1):61-69. PubMed ID: 33452083
[TBL] [Abstract][Full Text] [Related]
58. Summaries for patients. Stool DNA and occult blood testing to screen for colorectal neoplasia.
Ann Intern Med; 2008 Oct; 149(7):I20. PubMed ID: 18838720
[No Abstract] [Full Text] [Related]
59. Diagnostic accuracy of multitarget stool DNA testing for colorectal cancer screening: A systematic review and meta-analysis.
Dolatkhah R; Dastgiri S; Jafarabadi MA; Abdolahi HM; Somi MH
Gastroenterol Hepatol; 2022 Dec; 45(10):753-766. PubMed ID: 35101601
[TBL] [Abstract][Full Text] [Related]
60. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
